I agree that this site is using cookies. You can find further informations here.
X
Ribaldone, D G
208  results:
english X
Search for persons X
?
1

P621 Safety and effectiveness of vedolizumab and ustekinuma..:

Holvoet, T ; Verstockt, B ; Lenfant, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1195-i1196 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P1016 Real-world data on sequential therapy in moderate-to-..:

Farkas, B ; Borsos, M ; Resál, T...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1837-i1838 , 2024
Link: https://doi.org/10.1093/..
 
?
3

P508 Pre-operative exposure to tofacitinib is as safe as bi..:

Dragoni, G ; Innocenti, T ; Amiot, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1005-i1006 , 2024
Link: https://doi.org/10.1093/..
 
?
4

A 1-year follow-up study on checkpoint inhibitor-induced co..:

Lenti, M.V. ; Ribaldone, D.G. ; Borrelli de Andreis, F....
ESMO Open.  9 (2024)  7 - p. 103632 , 2024
Link: https://doi.org/10.1016/..
 
?
5

P576 Fecal calprotectin could predict clinical and endoscop..:

Bertani, L ; Tricò, D ; Barberio, B...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1125-i1125 , 2024
Link: https://doi.org/10.1093/..
 
?
6

P729 Prospective observational study evaluating the effects..:

Piumatti, A ; Beccuti, G ; Armandi, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1369-i1369 , 2024
Link: https://doi.org/10.1093/..
 
?
7

OC.04.7: A ONE-YEAR FOLLOW-UP STUDY ON CHECKPOINT INHIBITOR..:

Lenti, M.V. ; Broglio, G. ; Ribaldone, D.G....
Digestive and Liver Disease.  56 (2024)  - p. S144-S145 , 2024
Link: https://doi.org/10.1016/..
 
?
8

OC.07.2: ASSESSMENT OF VEDOLIZUMAB AND USTEKINUMAB IN ELDER..:

Viola, A. ; Ventimiglia, M. ; Sparacino, A....
Digestive and Liver Disease.  56 (2024)  - p. S161-S163 , 2024
Link: https://doi.org/10.1016/..
 
?
9

P908 Real-life effectiveness and safety of tofacitinib and ..:

Noviello, D ; Savarino, E ; Fries, W...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1660-i1661 , 2024
Link: https://doi.org/10.1093/..
 
?
10

DOP79 Promising efficacy of biologicals and small molecules..:

Verstockt ., B ; Taelman, T ; Vavricka, S R...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i219-i221 , 2024
Link: https://doi.org/10.1093/..
 
?
11

BOC.03.3: TREATMENT OF ANTIBIOTIC REFRACTORY CHRONIC POUCHI..:

Testa, G. ; Ribaldone, D.G. ; Verstockt, B....
Digestive and Liver Disease.  56 (2024)  - p. S115-S116 , 2024
Link: https://doi.org/10.1016/..
 
?
12

P539 Assessment of VEdolizumab aNd Ustekinumab in Elderly p..:

Viola, A ; Ventimiglia, M ; Sparacino, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1059-i1061 , 2024
Link: https://doi.org/10.1093/..
 
?
13

Effect of Periodontitis and Periodontal Therapy on Oral and..:

Baima, G. ; Ferrocino, I. ; Del Lupo, V....
Journal of Dental Research.  103 (2024)  4 - p. 359-368 , 2024
Link: https://doi.org/10.1177/..
 
?
14

P612 Switching from intravenous to subcutaneous VEDOlizumab..:

Ribaldone, D G ; Parisio, L ; Variola, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1185-i1185 , 2024
Link: https://doi.org/10.1093/..
 
?
15

P735 JAK inhibitors and S1P receptor modulators for the tre..:

Testa, G ; Ribaldone, D G ; Verstockt, B...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1377-i1379 , 2024
Link: https://doi.org/10.1093/..
 
1-15